Liberty Mutual Group Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-51,974
Closed -$4.01M – 326
2018
Q3
$4.01M Hold
51,974
– – 0.08% 77
2018
Q2
$3.68M Sell
51,974
-75
-0.1% -$5.3K 0.09% 80
2018
Q1
$3.92M Hold
52,049
– – 0.12% 76
2017
Q4
$3.73M Sell
52,049
-2,313
-4% -$176K 0.11% 76
2017
Q3
$4.4M Sell
54,362
-29,554
-35% -$2.26M 0.24% 61
2017
Q2
$5.94M Buy
83,916
+11,585
+16% +$771K 0.24% 63
2017
Q1
$4.91M Sell
72,331
-24,544
-25% -$1.73M 0.19% 79
2016
Q4
$6.94M Sell
96,875
-21,282
-18% -$1.58M 0.25% 60
2016
Q3
$9.35M Buy
118,157
+2,537
+2% +$206K 0.33% 43
2016
Q2
$9.64M Sell
115,620
-3,054
-3% -$271K 0.35% 42
2016
Q1
$10.9M Buy
118,674
+31,549
+36% +$2.85M 0.45% 29
2015
Q4
$8.81M Buy
87,125
+37,245
+75% +$3.88M 0.35% 36
2015
Q3
$4.9M Sell
49,880
-1,544
-3% -$171K 0.19% 72
2015
Q2
$6.02M Sell
51,424
-25,273
-33% -$2.76M 0.21% 55
2015
Q1
$7.53M Buy
76,697
+1,145
+2% +$116K 0.23% 39
2014
Q4
$7.12M Sell
75,552
-1,632
-2% -$169K 0.22% 46
2014
Q3
$8.22M Sell
77,184
-1,382
-2% -$135K 0.27% 31
2014
Q2
$6.51M Sell
78,566
-173
-0.2% -$13.5K 0.21% 54
2014
Q1
$5.58M Buy
78,739
+3,228
+4% +$253K 0.18% 65
2013
Q4
$5.67M Sell
75,511
-16,908
-18% -$1.18M 0.2% 56
2013
Q3
$5.81M Buy
92,419
+19,544
+27% +$1.17M 0.22% 56
2013
Q2
$3.74M Buy
+72,875
New +$3.8M 0.15% 155

Other funds holding GILD

Liberty Mutual Group Asset Management's GILD Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 51,974 shares — an estimated $4.01M sold.

Liberty Mutual Group Asset Management first reported a position in GILD in Q2 2013 and held it in 22 quarters. The position peaked at $10.9M in Q1 2016. 1,498 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 51,974 Gilead Sciences shares in Q4 2018, an estimated $4.01M.
  • Liberty Mutual Group Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 22 quarters.
  • Liberty Mutual Group Asset Management's Gilead Sciences position peaked at $10.9M in Q1 2016.
  • 1,498 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.